MAX Surgical Specialty Management Strengthens Clinical Advisory Board with New Appointments

MAX Surgical Specialty Management Strengthens Clinical Advisory Board

MAX Surgical Specialty Management, a prominent surgeon-led platform for oral and maxillofacial surgery (OMS), has recently appointed two esteemed professionals, Dr. Margo J. Freedberg and Dr. Sung Hee Cho, to key positions in its Clinical Advisory Board. This strategic move not only reflects the company's commitment to excellence but also aims to support its expanding network of surgeons across the Northeast.

Growth and Development of MAX

In 2024, MAX witnessed a significant increase in its network of surgeons, with growth approaching 40%. This surge in affiliations underscores the need for enhanced leadership and strategic direction, prompting the leadership team at MAX to strengthen its Clinical Advisory Board.

As the newly appointed Medical Director, Dr. Freedberg will be pivotal in developing and overseeing MAX's clinical strategic goals, services, and surgical programs. On the other hand, Dr. Cho will take on the role of Chief Medical Officer, continuing his mentoring and industry involvement while leading new associates at MAX. Dr. Cho, who was previously the Medical Director and a co-founder, is deeply committed to advancing practices within the medical community.

Vision for the Future

"When we started MAX, our goal was to create opportunities for leading oral surgeons who are dedicated to their specialties and keen on contributing to the advancement of OMS," said Dr. Jason M. Auerbach, Founder and Co-CEO of MAX. "The appointments of Dr. Freedberg and Dr. Cho further this vision, aiming to create an environment where surgeons can prioritize patient outcomes while continuing to thrive professionally."

The MAX Clinical Advisory Board comprises nationally renowned oral and maxillofacial surgeons who are instrumental in shaping the organization’s commitment to clinical excellence, innovation, and patient-centered care. The collaboration among members emphasizes best practices, ensuring that the surgeons’ work aligns seamlessly with an ever-evolving healthcare landscape.

Dr. Margo J. Freedberg

Dr. Freedberg is a highly experienced oral and maxillofacial surgeon with over 25 years in practice. She is board-certified and a fellow of the American Association of Oral and Maxillofacial Surgeons. Her expertise includes diverse oral surgery procedures, notably dental implants, bone grafting, and wisdom tooth extractions. Dr. Freedberg graduated from the University of Pennsylvania School of Dental Medicine and has been a valuable member of the Riverside Oral Surgery team, a practice associated with MAX, since its merger.

Her leadership role also extends to her long-standing relationship with Overlook Medical Center, where she has served as Chief of Oral Surgery, emphasizing her commitment to healthcare excellence in the region.

Dr. Sung Hee Cho

Dr. Cho brings a wealth of knowledge to his role as Chief Medical Officer, being a dual-degree board-certified oral and maxillofacial surgeon. Following his training at prestigious institutions like Columbia University and Emory University, he focused on the complete spectrum of OMS while specializing in managing oral cavity cancers and conducting microvascular reconstructive surgeries.

Dr. Cho's commitment to clinical practice and education makes him a vital asset to MAX. His subsequent affiliation with Riverside Oral Surgery ensures that his extensive experience directly benefits MAX and its network of surgeons.

MAX's Comprehensive Support System

Founded in 2022, MAX Surgical Specialty Management is the Northeast’s first management platform dedicated solely to oral and maxillofacial surgery. It offers extensive operational support alongside cutting-edge technology, allowing practices to enhance their efficiency and collaborative efforts.

The integration of Dr. Freedberg and Dr. Cho into the leadership emphasizes MAX's commitment to safeguarding surgeon independence while providing robust support systems tailored for growth. They aim to empower surgeons and establish best practices that align with the leading standards of patient care in the field.

In a landscape where clinical innovation meets operational excellence, MAX is poised to lead the way, ensuring that patient outcomes remain the top priority across its practices. With Dr. Freedberg's and Dr. Cho's guidance, MAX looks forward to not only maintaining high standards but also setting new benchmarks for the oral and maxillofacial surgery community.